205 related articles for article (PubMed ID: 17258913)
1. Analysis of the nonclinical telemetered ECG: impact of logging rate and RR bin width in the dog and cynomolgus monkey.
Holzgrefe HH; Cavero I; Gleason CR
J Pharmacol Toxicol Methods; 2007; 56(1):34-42. PubMed ID: 17258913
[TBL] [Abstract][Full Text] [Related]
2. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys.
Holzgrefe HH; Cavero I; Gleason CR; Warner WA; Buchanan LV; Gill MW; Burkett DE; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(2):159-75. PubMed ID: 16857392
[TBL] [Abstract][Full Text] [Related]
3. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
4. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
Batey AJ; Doe CP
J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
[TBL] [Abstract][Full Text] [Related]
5. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
Koga T; Kuwano K; Kito G; Kanefuji K
J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
[TBL] [Abstract][Full Text] [Related]
7. Calculation of QT shift in non clinical safety pharmacology studies.
Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
[TBL] [Abstract][Full Text] [Related]
8. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.
Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M
J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033
[TBL] [Abstract][Full Text] [Related]
9. Assessing QT prolongation in conscious dogs: validation of a beat-to-beat method.
Fossa AA
Pharmacol Ther; 2008 May; 118(2):231-8. PubMed ID: 18420278
[TBL] [Abstract][Full Text] [Related]
10. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
[TBL] [Abstract][Full Text] [Related]
11. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
12. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
Tattersall ML; Dymond M; Hammond T; Valentin JP
J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
[TBL] [Abstract][Full Text] [Related]
13. Assessing QT prolongation and electrocardiography restitution using a beat-to-beat method.
Fossa AA; Zhou M
Cardiol J; 2010; 17(3):230-43. PubMed ID: 20535712
[TBL] [Abstract][Full Text] [Related]
14. The electrocardiogram of the Beagle dog: reference values and effect of sex, genetic strain, body position and heart rate.
Hanton G; Rabemampianina Y
Lab Anim; 2006 Apr; 40(2):123-36. PubMed ID: 16600072
[TBL] [Abstract][Full Text] [Related]
15. [The automatic, beat-to-beat determination of the QT interval and analysis of its spontaneous variability under basal conditions].
Chorro Gascó FJ; Guerrero Martínez J; Martínez Sober M; Soria Olivas E; Sanchís Forés J; Ibáñez Candela M; Espí López J; López Merino V
Rev Esp Cardiol; 1995 Nov; 48(11):722-31. PubMed ID: 8532941
[TBL] [Abstract][Full Text] [Related]
16. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
Markert M; Shen R; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
Prior H; McMahon N; Schofield J; Valentin JP
J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
[TBL] [Abstract][Full Text] [Related]
18. Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval.
Malik M; Hnatkova K; Kowalski D; Keirns JJ; van Gelderen EM
J Electrocardiol; 2012; 45(6):571-81. PubMed ID: 22999325
[TBL] [Abstract][Full Text] [Related]
19. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
Bass AS; Hanson LA; Jackson TA
J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
[TBL] [Abstract][Full Text] [Related]
20. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
